860780P
α-Galactosyl FP20
Manufacturer: Sigma Aldrich
Synonym(S): 6-O-α-D-Galactopyranosyl-1β,2N,3-tridodecanoyl-D-glucosamine-4-phosphate, sodium salt
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 860780P-5MG | 860780P-860780P-5MG | In Stock | ₹ 54,060.05 |
860780P - 860780P-5MG
In Stock
Quantity
1
Base Price: ₹ 54,060.05
GST (18%): ₹ 9,730.809
Total Price: ₹ 63,790.859
biological source
synthetic
Assay
≥99% (TLC)
form
powder
packaging
pkg of 1 × 5 mg (860780P-5MG)
manufacturer/tradename
Avanti Polar Lipids
application(s)
vaccine development
shipped in
dry ice
storage temp.
−20°C
SMILES string
CCCCCCCCCCCC(=O)NC1C(OC(=O)CCCCCCCCCCC)OC(COC2OC(CO)C(O)C(O)C2O)C(OP(O)(=O)O[Na])C1OC(=O)CCCCCCCCCCC
Related Products
Description
- Application: Vaccine development
- Packaging: 5 mL Amber Glass Screw Cap Vial (860780P-5MG)
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: synthetic
Assay: ≥99% (TLC)
form: powder
packaging: pkg of 1 × 5 mg (860780P-5MG)
manufacturer/tradename: Avanti Polar Lipids
application(s): vaccine development
shipped in: dry ice
storage temp.: −20°C
SMILES string: CCCCCCCCCCCC(=O)NC1C(OC(=O)CCCCCCCCCCC)OC(COC2OC(CO)C(O)C(O)C2O)C(OP(O)(=O)O[Na])C1OC(=O)CCCCCCCCCCC
biological source:
synthetic
Assay:
≥99% (TLC)
form:
powder
packaging:
pkg of 1 × 5 mg (860780P-5MG)
manufacturer/tradename:
Avanti Polar Lipids
application(s):
vaccine development
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
CCCCCCCCCCCC(=O)NC1C(OC(=O)CCCCCCCCCCC)OC(COC2OC(CO)C(O)C(O)C2O)C(OP(O)(=O)O[Na])C1OC(=O)CCCCCCCCCCC
biological source: synthetic
Assay: ≥99% (TLC)
form: powder
packaging: pkg of 1 × 5 mg (860782P-5MG)
manufacturer/tradename: Avanti Polar Lipids
application(s): vaccine developmentvaccine development
shipped in: dry ice
storage temp.: −20°C
SMILES string: CCCCCCCCCCCC(=O)NC1C(OC(=O)CCCCCCCCCCC)OC(COC2OC(CO)C(O)C(O)C2O)C(OP(O)(=O)O[Na])C1OC(=O)CCCCCCCCCCC
biological source:
synthetic
Assay:
≥99% (TLC)
form:
powder
packaging:
pkg of 1 × 5 mg (860782P-5MG)
manufacturer/tradename:
Avanti Polar Lipids
application(s):
vaccine developmentvaccine development
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
CCCCCCCCCCCC(=O)NC1C(OC(=O)CCCCCCCCCCC)OC(COC2OC(CO)C(O)C(O)C2O)C(OP(O)(=O)O[Na])C1OC(=O)CCCCCCCCCCC
biological source: __
Assay: 98%
form: powder
packaging: __
manufacturer/tradename: __
application(s): peptide synthesis
shipped in: __
storage temp.: −20°C
SMILES string: ClCC(=O)[C@H](Cc1ccccc1)NC(=O)OCc2ccccc2
biological source:
__
Assay:
98%
form:
powder
packaging:
__
manufacturer/tradename:
__
application(s):
peptide synthesis
shipped in:
__
storage temp.:
−20°C
SMILES string:
ClCC(=O)[C@H](Cc1ccccc1)NC(=O)OCc2ccccc2
biological source: __
Assay: __
form: powder
packaging: pkg of 1 × 5 mg (860811P-5mg)
manufacturer/tradename: Avanti Polar Lipids 860811P
application(s): __
shipped in: dry ice
storage temp.: −20°C
SMILES string: CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC([C@H](O)CCCCCCCCCC)=O)CO
biological source:
__
Assay:
__
form:
powder
packaging:
pkg of 1 × 5 mg (860811P-5mg)
manufacturer/tradename:
Avanti Polar Lipids 860811P
application(s):
__
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC([C@H](O)CCCCCCCCCC)=O)CO